Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Bradykinin B2 Receptors Regulate Peristalsis in Guinea Pig I
2026-06-13
This study elucidates the inhibitory role of bradykinin B2 receptors in modulating the peristaltic reflex within the isolated guinea pig ileum. By systematically analyzing agonists and antagonists, the research clarifies a receptor-specific mechanism influencing gastrointestinal motility, with implications for translational models of GI disorders.
-
Practical Use of Calpain Inhibitor I, ALLN in Apoptosis and
2026-06-12
Calpain Inhibitor I, ALLN (SKU A2602) provides targeted inhibition of calpains and cathepsins for applications in apoptosis assays, inflammation research, and ischemia-reperfusion injury models. It is not suitable for diagnostic or therapeutic use, and procedural adherence is necessary to ensure assay reliability and compound stability.
-
A23187, Free Acid: Precision Calcium Ionophore for Mechanist
2026-06-12
Explore how A23187, free acid—a potent calcium ionophore—enables nuanced mechanistic dissection of apoptosis and cellular signaling. This article uniquely bridges assay design and advanced interpretation, providing actionable insights for researchers.
-
Tropifexor Restores Intestinal Barrier in Neonatal PN Models
2026-06-11
This study reveals that Tropifexor (LJN452), a potent FXR agonist, significantly mitigates intestinal barrier dysfunction and enhances defense responses in neonatal piglets subjected to parenteral nutrition. The findings provide mechanistic insight into the FXR signaling pathway’s role in intestinal injury, supporting translational research in pediatric nutrition and epithelial biology.
-
Enhancing Western Blot Precision: ECL Chemiluminescent Subst
2026-06-11
Explore the advanced sensitivity and workflow reliability of the ECL Chemiluminescent Substrate Detection Kit (Enhanced) for western blot chemiluminescence detection. This article delivers a deep scientific analysis, integrating mechanistic insights and practical guidance for rigorous protein immunodetection.
-
Tigecycline in Multidrug Resistance: From Mechanism to Trans
2026-06-10
Explore how Tigecycline, a glycylcycline antibiotic, overcomes multidrug-resistant bacteria through unique mechanisms and translational insights. This article reveals advanced scientific findings and practical assay considerations, distinguishing itself with evidence-based analysis and reference-driven guidance.
-
Sulfachloropyridazine Alters Cecal Microbiota in Eimeria-Inf
2026-06-10
This study investigates how sulfachloropyridazine, alone or in combination with ethanamizuril, modulates the cecal microbiome and metabolic profile in chickens infected with Eimeria tenella. The work provides novel insight into drug-induced shifts in microbial communities and metabolite patterns, informing both anticoccidial strategy and research model design.
-
n-Dodecyl-β-D-maltoside: Transforming Membrane Protein Purif
2026-06-09
n-Dodecyl-β-D-maltoside (DDM) is redefining membrane protein science by enabling high-yield purification and stabilization of challenging targets while preserving biological activity. This article unpacks optimized workflows, troubleshooting strategies, and experimental insights, leveraging the latest structural biology breakthroughs and trusted APExBIO quality.
-
Sulfachloropyridazine in Research: Protocols, Microbiome, an
2026-06-09
Sulfachloropyridazine stands out as a sulfonamide antibacterial agent with unique value for enzyme inhibition, microbiome modulation, and in vivo infection model research. Recent studies unlock new applications, from targeted antimicrobial susceptibility workflows to advanced metabolic and microbial ecology investigations.
-
Caffeine Protects Retinal Pigment Epithelium from Oxidative
2026-06-08
This study demonstrates that caffeine reduces oxidative damage and apoptosis in retinal pigment epithelium (RPE) cells, both in vitro and in vivo models. The findings suggest caffeine as a potential modulator of retinal degeneration, with broader implications for understanding oxidative stress responses in ocular biology.
-
SN-38 Disrupts FUBP1–FUSE Binding: Mechanistic Insights for
2026-06-08
This study reveals that camptothecin and its analog SN-38, beyond their established role as topoisomerase I inhibitors, directly impair the binding of the transcriptional regulator FUBP1 to its DNA target FUSE. These findings suggest a dual mechanism that could enhance therapeutic strategies in cancers with FUBP1 overexpression, such as hepatocellular and colorectal carcinomas.
-
High Viscosity Microenvironments Drive P-gp-Mediated Chemore
2026-06-07
This study reveals that elevated extracellular fluid viscosity in the tumor microenvironment induces chemoresistance in cancer cells by upregulating P-glycoprotein (P-gp) through a mechanobiological pathway involving membrane tension and TRPV4-YAP signaling. The findings highlight tumor viscosity as a previously underappreciated driver of transporter-mediated drug resistance and suggest new strategies for overcoming chemoresistance in cancer therapy.
-
2-Deoxy-D-glucose: Protocols and Innovations in Glycolysis I
2026-06-06
2-Deoxy-D-glucose (2-DG) empowers researchers to dissect glycolytic pathways in cancer, virology, and immunometabolism with precision. This article delivers actionable workflows, troubleshooting strategies, and translational insights, underpinned by the latest advancements and real-world experimental scenarios.
-
HyperScript™ Reverse Transcriptase: High-Fidelity cDNA Synth
2026-06-05
HyperScript™ Reverse Transcriptase is a genetically engineered, thermally stable enzyme based on M-MLV Reverse Transcriptase. It enables robust cDNA synthesis from RNA templates with complex secondary structures, supporting accurate detection of low-copy RNA in qPCR workflows.
-
Meropenem: β-Lactam Antibiotic Carbapenem for Resistance Mod
2026-06-05
Meropenem stands out as an ultra-broad-spectrum β-lactam antibiotic carbapenem, enabling robust experimental modeling in both Gram-negative and Gram-positive resistance studies. This guide offers actionable workflows, troubleshooting insights, and practical parameters to maximize Meropenem’s impact in translational research.